ALLOVIR INC (ALVR)
US0198181036 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to ALVR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.53. This target is 240% above the current price.
ALVR was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ALVR.
In the previous month the buy percentage consensus was at a similar level.
ALVR was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-26 | B of A Securities | Downgrade | Buy -> Underperform |
| 2023-12-22 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2023-12-22 | JP Morgan | Downgrade | Overweight -> Underweight |
| 2023-12-22 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-08-18 | B of A Securities | Initiate | Buy |
| 2023-08-07 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-04-26 | SVB Securities | Maintains | Outperform |
| 2023-01-27 | Morgan Stanley | Maintains | Overweight |
| 2023-01-23 | SVB Leerink | Maintains | Outperform |
| 2022-11-07 | SVB Leerink | Maintains | Outperform |
| 2022-09-09 | Morgan Stanley | Maintains | Overweight |
| 2022-07-28 | SVB Leerink | Maintains | Outperform |
| 2022-05-19 | Piper Sandler | Maintains | Overweight |
| 2022-02-10 | SVB Leerink | Maintains | Outperform |
| 2022-02-01 | BMO Capital | Initiate | Outperform |
| 2022-01-18 | Morgan Stanley | Maintains | Overweight |
| 2021-12-17 | SVB Leerink | Maintains | Outperform |
| 2021-11-08 | SVB Leerink | Maintains | Outperform |
| 2021-10-12 | Morgan Stanley | Maintains | Overweight |
| 2021-09-29 | Morgan Stanley | Maintains | Overweight |
| 2021-08-18 | Morgan Stanley | Maintains | Overweight |
| 2021-05-06 | SVB Leerink | Maintains | Outperform |
| 2021-04-19 | Morgan Stanley | Maintains | Overweight |